Lunai Bioworks Income Statement (2011-2026) | LNAI

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.02M
Cost of Revenue (Quarter)
7.50M6.33M4.03M
Gross Profit (Quarter)
0.02M
Operating items
Depreciation & Amortization - Total (Quarter)
0.03M0.03M0.03M0.03M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Research & Development (Quarter)
12.15M3.06M2.34M1.21M1.77M2.61M0.33M0.24M0.99M0.57M0.62M1.09M0.43M0.39M0.16M-0.09M0.08M0.02M0.05M0.02M
Selling, General & Administrative (Quarter)
2.01M4.42M3.96M2.79M3.16M4.56M4.01M3.80M2.95M8.29M3.62M7.65M5.00M5.30M4.35M4.22M4.00M2.41M1.77M1.42M
Restructuring Costs (Quarter)
0.05M0.19M4.35M4.22M4.00M2.41M1.77M1.42M
Other Operating Expenses (Quarter)
0.00M-0.05M-0.19M0.00M93.26M0.00M0.00M0.00M18.96M-13.15M0.01M42.61M-49.95M47.65M-4.32M-4.19M118.84M-1.54M-1.75M-1.41M
Operating Expenses (Quarter)
14.18M7.50M6.33M4.03M98.21M7.19M4.37M4.06M22.93M8.88M4.27M51.38M17.10M53.34M4.55M4.16M126.92M3.31M1.82M1.45M
Operating Income (Quarter)
-14.18M-7.50M-6.33M-4.03M-98.21M-7.19M-4.37M-4.06M-22.93M-8.88M-4.27M-51.38M-17.10M-53.34M-4.55M-4.16M-126.92M-3.31M-1.82M-1.48M
EBIT (Quarter)
-14.18M-7.50M-6.33M-4.03M-98.21M-7.19M-4.37M-4.06M-22.93M-8.88M-4.27M-51.38M-17.10M-53.34M-4.55M-4.16M-126.92M-3.31M-1.82M-1.48M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.01M0.01M0.01M0.10M0.01M0.00M-0.14M0.01M-0.02M0.13M
Other Non Operating Income (Quarter)
-124.009.00-0.42M0.29M-0.12M-1.30M0.13M0.12M-6.33M-0.02M
Non Operating Income (Quarter)
-3.18M-2.91M-0.25M-2.17M7.97M-0.51M-0.09M-0.26M-0.26M-0.29M-0.26M-7.61M1.37M9.13M-2.71M4.35M0.19M6.13M0.02M-1.14M
Net income details
EBT (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.70M-17.36M-53.46M-4.65M-4.35M-127.11M-3.43M-1.94M-1.59M
Tax Provisions (Quarter)
-475.0034.00
Profit After Tax (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.53M-58.99M-15.73M-44.21M-7.25M0.19M-126.73M2.82M-1.80M-2.57M
Equity Income (Quarter)
0.21M
Income from Continuing Operations (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.70M-17.36M-53.46M-4.65M-4.35M-127.11M-3.43M-1.94M-1.59M
Consolidated Net Income (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.70M-17.36M-53.46M-4.65M-4.35M-127.11M-3.43M-1.94M-1.59M
Income towards Parent Company (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.70M-17.36M-53.46M-4.65M-4.35M-127.11M-3.43M-1.94M-1.59M
Net Income towards Common Stockholders (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.70M-17.36M-53.46M-4.65M-4.35M-127.11M-3.43M-1.94M-1.59M
Additional items
EPS (Basic) (Quarter)
-0.37-0.20-0.13-0.12-1.72-0.14-0.08-0.08-0.41-0.14-0.07-0.54-0.18-2.76-0.45-0.272.100.13-0.08-0.10
EPS (Weighted Average and Diluted) (Quarter)
-1.72-0.14-0.08-0.08-0.41-0.14-0.07-0.54-0.18-2.76-0.45-0.272.100.13-0.08-0.10
Shares Outstanding (Weighted Average) (Quarter)
47.17M52.22M52.27M52.39M52.53M55.10M55.30M55.97M56.27M64.48M5.83M109.25M97.51M16.00M16.09M16.14M165.06M22.52M23.13M24.99M
Shares Outstanding (Diluted Average) (Quarter)
52.53M55.10M55.51M55.97M56.27M64.48M65.17M79.75M97.51M16.00M16.18M16.39M165.06M22.52M23.48M23.74M
EBITDA (Quarter)
-14.16M-7.48M-6.30M-4.01M-98.18M-7.16M-4.45M-4.04M-22.91M-8.86M-4.49M-51.35M-17.07M-53.34M-4.55M-4.16M-126.92M-3.31M-1.82M-1.48M
Interest Expenses (Quarter)
0.10M0.09M0.09M0.10M-0.27M0.10M0.00M0.12M0.27M0.18M0.27M0.30M0.25M0.25M0.10M0.19M0.19M0.12M0.12M0.11M
Tax Rate (Quarter)
0.00%0.00%